000 01258 a2200301 4500
005 20250513222821.0
264 0 _c20010329
008 200103s 0 0 eng d
022 _a1043-2760
024 7 _a10.1016/s1043-2760(00)00311-8
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSchmidt, A M
245 0 0 _aRAGE: a new target for the prevention and treatment of the vascular and inflammatory complications of diabetes.
_h[electronic resource]
260 _bTrends in endocrinology and metabolism: TEM
_cNov 2000
300 _a368-75 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.; Review
650 0 4 _aAnimals
650 0 4 _aDiabetes Complications
650 0 4 _aDiabetic Angiopathies
_xdrug therapy
650 0 4 _aGlycation End Products, Advanced
_xmetabolism
650 0 4 _aHumans
650 0 4 _aInflammation
_xdrug therapy
650 0 4 _aReceptor for Advanced Glycation End Products
650 0 4 _aReceptors, Immunologic
_xdrug effects
700 1 _aStern, D M
773 0 _tTrends in endocrinology and metabolism: TEM
_gvol. 11
_gno. 9
_gp. 368-75
856 4 0 _uhttps://doi.org/10.1016/s1043-2760(00)00311-8
_zAvailable from publisher's website
999 _c10987462
_d10987462